Inspire Investing’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
SL
Inspire Investing's RCUS Position: Q3 2026 in Review
Inspire Investing reduced its Arcus Biosciences (RCUS) stake by 100% in Q3 2026, selling an estimated $10.9K and leaving 1 share worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #1264.
Inspire Investing first reported a position in RCUS in Q3 2022 and has held it in 8 quarters since. The position peaked at $311K in Q2 2023. 171 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Inspire Investing held 1 share of Arcus Biosciences worth $31 as of Q3 2026.
- Inspire Investing sold 385 Arcus Biosciences shares in Q3 2026, an estimated $10.9K.
- Arcus Biosciences made up ﹤0.01% of Inspire Investing's portfolio in Q3 2026, its #1264 holding.
- Inspire Investing first reported a position in Arcus Biosciences in Q3 2022 and has held it in 8 quarters since.
- Inspire Investing's Arcus Biosciences position peaked at $311K in Q2 2023.
- 171 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.